EGFR c.1340_1341delinsAA ;(p.S447*)

Variant ID: 7-55227873-CC-AA

NM_005228.3(EGFR):c.1340_1341delinsAA;(p.S447*)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Current approaches of nanomedicines in the market and various stage of clinical translation.

Acta Pharmaceutica Sinica. B
Shan, Xiaoting X; Gong, Xiang X; Li, Jie J; Wen, Jingyuan J; Li, Yaping Y; Zhang, Zhiwen Z
Publication Date: 2022-07

Variant appearance in text: EGFR: S447X
PubMed Link: 35865096
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page



Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
Wagner, Hanna J HJ; Weber, Wilfried W; Fussenegger, Martin M
Publication Date: 2021-05

Variant appearance in text: EGFR: S447X
PubMed Link: 33977059
Variant Present in the following documents:
  • Main text
View BVdb publication page



AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer.

Molecular Therapy : The Journal Of The American Society Of Gene Therapy
Verdera, Helena Costa HC; Kuranda, Klaudia K; Mingozzi, Federico F
Publication Date: 2020-03-04

Variant appearance in text: EGFR: S447X
PubMed Link: 31972133
Variant Present in the following documents:
  • Main text
View BVdb publication page